Searched for
ONYX BIO
Meet Roger Chen and Amit Lakhani, who started Onyx Bio to build a 'virtual immune system'; in 2026, the startup raised $8 millionOnyx Bio is based in Berkeley, California. It announced the funding on October 8, 2026. The round was led by Dimension Capital. It had part...- Midcap stocks with ‘strong buy’ & ‘buy’ recos can rally over 25%, according to analystsET screener powered by Refinitiv’s Stock Report Plus lists down quality stocks with high upside potential over the next 12 months, having a...
- Midcap stocks with ‘strong buy’ & ‘buy’ recos can rally over 25%, according to analystsET screener powered by Refinitiv’s Stock Report Plus lists down quality stocks with high upside potential over the next 12 months, having a...
- Midcap stocks with ‘strong buy’ & ‘buy’ recos can rally over 25%, according to analystsET screener powered by Refinitiv’s Stock Report Plus lists down quality stocks with high upside potential over the next 12 months, having a...
- Midcap stocks with ‘strong buy’ & ‘buy’ reco which can rally over 25%, according to analystsET screener powered by Refinitiv’s Stock Report Plus lists down quality stocks with high upside potential over the next 12 months, having a...
- Even as bears stay in control of Nifty, midcap stocks with ‘strong buy’ & ‘buy’ ratings can rally over 25%, say analystsNifty in a correction mode and how much time it will stay in that mode, it is anyone's guess. For all those who are busy guessing how thing...
- Capping stent prices will halt new launches, says industryThe process may require the drug pricing watchdog to look at a set of separate parameters for these devices as compared to that for drugs.
- Big Pharma seeks biotech dose to spur growthVincent Aita of Kilkenny Capital Management says he picks biotechnology stocks on their potential as takeover targets.
Load More